| Literature DB >> 29534986 |
Geoffrey D Barnes1, Erin Mouland2.
Abstract
Peri-procedural management of oral anticoagulants can be complex and confusing for many providers. It involves a careful balance of a patient's thromboembolic risk and bleeding risk. For every patient chronically taking an oral anticoagulant who will be undergoing an elective procedure, a four step approach may be considered when creating a plan for the oral anticoagulant. (1) Does the oral anticoagulant need to stop for the procedure? (2) If yes, when should the oral anticoagulant be stopped pre-procedure? (3) Does the patient require a "bridging" parenteral anticoagulant? (4) When should anticoagulation be re-started post procedure? Based on the unique features of warfarin versus the direct oral anticoagulants (DOAC), a unique, personalized plan should be developed and tailored to the individual patient. Anticoagulant specialists, such as anticoagulation clinic pharmacists, may help facilitate this process.Entities:
Keywords: Direct oral anticoagulant (DOAC); Oral anticoagulant; Peri-procedural management; Warfarin
Mesh:
Substances:
Year: 2018 PMID: 29534986 PMCID: PMC5972056 DOI: 10.1016/j.pcad.2018.03.002
Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN: 0033-0620 Impact factor: 8.194